Physical Activity for Dialysis Patients, What is the Benefit? Dr Myriam ROUCHON ISNARD

Similar documents
COMPARISON OF EXISTING ANEMIA GUIDELINES WORLDWIDE. R Vanholder, University Hospital, Gent, Belgium

Comment on European Renal Best Practice Position Statement on Anaemia Management in Chronic Kidney Disease.

Feasibility, Safety, and Functional Impact of Physical Therapy During Hemodialysis: a Systematic Review

ANAEMIA MANAGEMENT: HOW AND WHY DOES ERBP DIFFER FROM KDIGO Francesco Locatelli, Lecco, Italy

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote

Efficacy and tolerability of oral Sucrosomial Iron in CKD patients with anemia. Ioannis Griveas, MD, PhD

ANEMIA & HEMODIALYSIS

Future Direction of Anemia Management in ESRD. Jay B. Wish, MD 2008 Nephrology Update March 20, 2008

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

PROs for Drug Development. Melanie Blank, MD

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Applying clinical guidelines treating and managing CKD

2011 Dialysis Facility Report

Chapter Five Clinical indicators & preventive health

2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

The Impact of Fatigue on Daily Activity in People with Chronic Kidney Disease

Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease

Department of Nephrology

The Hemodialysis Exercise Program

02/27/2018. Objectives. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis.

Andrea Pizutti, LCSW Gayle Hall, BSN, RN, CNN Regional Operations Director Area Director Davita NxStage Kidney Care

A treatment to fit your needs

KIDNEY DIALYSIS FOUNDATION ANNUAL REPORT PERITONEAL DIALYSIS PROGRAMME

Supplemental data to article. Association of ESA hypo-responsiveness and haemoglobin variability with. mortality in hemodialysis patients

ANEMIA OF CHRONIC KIDNEY DISEASE

Chronic Kidney Disease. Paul Cockwell Queen Elizabeth Hospital Birmingham

Morbidity & Mortality from Chronic Kidney Disease

PDF # IMPROVE BLOOD HEMOGLOBIN FOR KIDNEY PATIENTS DOCUMENT

A team s approach to QOL in CKD patients

Predicting and changing the future for people with CKD

How does exercise benefit people at risk for dementia?

Peer Review Report. [erythropoietin-stimulating agents]

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano

Dialysis: the long case

Dr B. Egger Service de Pneumologie Hôpital de Rolle

i. Where is the participant seen?

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

2008 Dialysis Facility Report

K atching Up with KDOQI: Clinical Practice Guidelines & Clinical Practice Recommendations for Anemia of Chronic Kidney Disease 2006

ANAEMIA MANAGEMENT: THE KDIGO RECOMMENDATIONS Patrick S. Parfrey, St. John s, Canada

Summary of Recommendation Statements Kidney International Supplements (2012) 2, ; doi: /kisup

KDIGO Controversies Conference on Blood Pressure in CKD

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Evidence-based practice in nephrology : Meta-analysis

2010 Dialysis Facility Report

EFFECTIVE SHARE CARE AGREEMENT

Iron metabolism anemia and beyond. Jacek Lange Perm, 8 October 2016

Vascular calcification in stage 5 Chronic Kidney Disease patients on dialysis

Taking Care of Your Kidneys

Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

Home Dialysis. Peritoneal Dialysis. Home Hemodialysis

Blood Pressure Treatment Goals

Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements

FIRST RENAL REPLACEMENT

Chronic Kidney Disease Clinical Practice Guidelines: Implementation Strategies

Case Study: Chris Arden. Peripheral Arterial Disease

Launch Meeting 3 rd April 2014, Lucas House, Birmingham


Dialysis for everyone? Maurizio Gallieni

Prevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis Adequacy

Living a Healthy Lifestyle DANINE FRUGE MD ASSOCIATE MEDICAL DIRECTOR PRITIKIN LONGEVITY CENTER MIAMI, FLORIDA

Date: / / Hello, my name is [interviewer name], and I'm calling to speak with [participant name]. Is [participant name] available?

NATIONAL QUALITY FORUM Renal EM Submitted Measures

Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables

TABLE OF CONTENTS T-1. A-1 Acronyms and Abbreviations. S-1 Stages of Chronic Kidney Disease (CKD)

CHRONIC RENAL FAILURE: WHAT THE PRIMARY CARE CAN OFFER. The annual conference of the Lebanese Society of Family Medicine October 2017 Dr Hiba AZAR

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA

chapter two clinical indicators and preventive care page

ANNEX FORM TO EXAMINE THE CAUSES OF ESRD I IDENTIFICATION. 1 Record number (patient chart) Name. 1.1 Date of birth / / 1.2 Sex:

ASDIN 7th Annual Scientific Meeting

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page

Current situation and future of renal anemia treatment. FRANCESCO LOCATELLI

Marginal Dialysis: Patient characteristics influencing outcomes

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health

Composite Performance Report

Thanks to our speaker!

2012 Dialysis Facility Report

Regular Aerobic Exercise Can Be an Effective Intervention to Reduce Blood Pressure

Intravenous Iron: A Good Thing Made Better? Marilyn Telen, MD Wellcome Professor of Medicine Duke University

Guideline Summary NGC-6019

UW MEDICINE PATIENT EDUCATION. Hemodialysis. A treatment option for kidney disease. Treatment Options for Kidney Disease

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases

Diane Watson, RN, MSc, C Neph (C) APN, Nephrology, UHN

Protecting the heart and kidney: implications from the SHARP trial

The Elderly Patient with Low egfr: Beyond a Disease-Oriented Approach. Maroun Azar, M.D.

HTA ET DIALYSE DR ALAIN GUERIN

Using the electronic medical records to identify patients with hypertension in primary care: A validation study using EMRALD.

No Disclosures 03/20/2019. Learning Objectives. Renal Anemia: The Basics

Research Journal of Pharmaceutical, Biological and Chemical Sciences

A tale of two specialties

Renal Nutrition Forum

Transcription:

Physical Activity for Dialysis Patients, What is the Benefit? Dr Myriam ROUCHON ISNARD

Hemodialysis Dialysis: Peritoneal Dialysis = Times eater 3 times a week 4 hours Center / Home Every day Home

And.

Whittink H. Manual Therapy 2011; 16: 209-16

Himmelfarb et al. 2000 Bay et al. 2009 Johansen KL. JASN 2007;18:1845-54

Physical Activity during Dialysis (1) Mortality Sedentary is associated with an increased risk of mortality (11% vs 5%) (O Hare AM et al. 2003) Myocardic Function Improvement of cardiovascular risk factors after an endurance exercise (Wilund KR et al. 2010 ; Kouidi et al.1998, Song WJ et al 2012) Vessels Reduction of systolic and diastolic pressure during and after dialysis (Anderson et al. 2004) Significant reduction of anti hypertensive treatment (Miller BW et al. 2002) Improvement of restless leg syndrom (Mortazavi M et al 2013)

Physical Activity during Dialysis (2) Nutrition Improvement of nutritional status and quality of life (Dialysis and comorbidity Pro inflammatory state) (Matsumoto Y et al. 2007) Oxydative Stress Improvement of the Oxydant Status (Atherosclerosis, denutrition, inflammation, accelerated aging process) (Kenneth et al. 2010 ; Pechter et al. 2003; Groussard, Rouchon Isnard et al. 2015) Quality of Life Physical Activity is correlated with reduction of depression score (Harris AH, et al. 2006, Song WJ et al. 2012)

Auvergne Typical Food: Truffade

Physical Activity Program Twice a week 20-30 minutes No resistance

Inclusion of Patients in the Physical Activity Program Agreement of the patient Volontarily Medical Agreement of the Nephrologist: Prescription of PA Agreement of the Cardiologist, Explorations if necessary Inclusion in the Program by the Sport s Teacher: Céline Coutard Functional Tests Objectives worked with the Patient Establishment during the Dialysis by the Nurses in charge of the Patient

15 Dialysis centers 500 HD patients 40% cycling 125 patients

Results at 3 Months Isoprostanes Groussard C, Rouchon Isnard M, Appl Physiol Nutr Metab. 2015 Jun;40(6):550-6.

Results at 3 Months TG level significantly reduced in EX (-23%) Groussard C, Rouchon Isnard M, Appl Physiol Nutr Metab. 2015 Jun;40(6):550-6.

Distance (number of revolutions) Results at 6 Months 6 cycling test Evaluation of the functional capacity of the patient. Adaptated from the 6 Walk Test. Easily reproductible during dialysis. 6 Minutes Cycling Test T0-T6 450 400 350 300 250 200 150 100 50 0 T0 + 26% P<0,05 T6 Rouchon Isnard M, ASN 2014.

- 130 000 euros / year Rouchon Isnard M, ASN 2014.

Quality Of Life: SF 36 QD Quality Of Life: SF 36 Evolution After 6 Months Cycling QOL scores 80 70 60 50 40 30 20 10 0 + 7% + 0.5% + 47% + 103% RP trans RE trans BP trans MH trans T0 T6 - Improvement of the limitations due to Physical status (RP) and Psychological status (RE) -BP : Body Pain -MH : Mental Health Rouchon Isnard M, ASN 2014.

1 Year Regular Perdialysis Cycling CON (n = 40) EX (n = 40) M0 M12 M0 M12 Age (years) 67,65 ± 13,4 66,8 ± 10,6 Gender 23m, 17f 27m, 13f Charlson comorbidity index 5,22 5,23 Ischemic cardiopathy 3 (7,5%) 7 (17,5%) Diabetes 12 (30%) 12 (30%) Hypertension Anti HTA treatments 33 (82,5%) 1,35 ± 1,02 1,22 ± 1,02 34 (85%) 1,85 ± 1,08 1,55 ± 0,85 * Hemoglobin (g.dl -1 ) 11,79 ± 1.01 11,35 ± 1,21 11,70 ± 1,17 12,06 ± 1,11 ** ESA doses 89,63 ± 77,3 120 ± 155,7 110,83 ± 70,8 103,06 ± 57,3 Time on dialysis (month) 63,6 ± 11.31 63,4 ± 3.53 Dialysis prescription (h/week) 12,11 ± 0,08 12,38 ± 1,41 Values are mean ± SD. CON : Control group ; EX : exercising-group * : difference between M0 and M12, p < 0,05 **: difference between EX and CON at M12, p< 0,05

1 Year Regular Perdialysis Cycling Number of Hospitalization for Cardiovascular Reasons Hospitalization = number of hospital stays EX 3 CON 20

1 Year Regular Perdialysis Cycling Figure 1: Evolution of the number of antihypertensive treatments / patient - 12 900 euros / year *: significant difference between M0 and M12 in EX, p < 0,05 Figure 2: Hb evolution Figure 3: ESA doses evolution *: significant difference at M12 between EX and CON, p < 0,05

What feel the patients? «The dialysis seems faster now I m cycling!» «Walk is easier now» «I ve bought a bicycle to continue at home» «My legs are lighter, I feel more flexible»

Peritoneal Dialysis Protocole 3 months.

Physical Activity for Transplanted Patients? Jonah Lomu All Black 2004 Post Transplantation Education Program for Transplanted Patients 2015

K/DOQI, KDIGO, ERBP Guidelines K/DOQI Clinical Practice Guidelines 2005: Many dialysis patients are severely deconditioned. The goal for physical activity should be moderate exercise intensity for 30 minutes most, if not all, days per week. KDIGO Clinical Practice Guidelines 2012: People with CKD undertake physical activity aiming for at least 30 minutes 5 times per week. ERBP Clinical Practice Guidelines 2015: For patients with Diabetes and CKD 3b or higher we suggest to perform individualized exercising 0,5-1 hour at least 3 times a week

Recommandations for patients with CKD Gansevoort R et al. Lancet 2013; 382:339-52,

CONCLUSION Physical Activity is a simple way to improve cardiovascular factors It allows people to create social connections And it saves money

Thank you for your attention dr.isnard@aura-auvergne.com myriam.isnard@free.fr